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Abstract: Multiple members of the let-7 family of miRNAs are
often repressed in human cancers, thereby promoting oncogenesis
by derepressing targets such as HMGA2, K-Ras and c-Myc. However,
the mechanism by which let-7 miRNAs are coordinately repressed is
unclear. The RNA-binding proteins lin28 and lin28B block let-7 pre-
cursors from being processed to mature miRNAs, suggesting that
their overexpression might promote malignancy through repression
of let-7. Here we show that lin28 and lin28B are overexpressed in
primary human tumors and human cancer cell lines (overall fre-
quency approximately 15%), and that overexpression is linked to
repression of let-7 family miRNAs and derepression of let-7 targets.
lin28 and lin28b facilitate cellular transformation in vitro, and over-
expression is associated with advanced disease across multiple tumor
types. Our work provides a mechanism for the coordinate repression
of let-7 miRNAs observed in a subset of human cancers, and associ-
ates activation of lin28 and lin28B with poor clinical prognosis.
Published by Elsevier B.V. on behalf of the European Association
for the Study of the Liver.
It is commonly believed that cancer arises as a consequence of
an imbalance in cellular homeostasis. The discovery of microR-
NAs (miRNAs) has opened a new era in the understanding of this
balance. A growing body of evidence indicates that miRNAs, such
as let-7 regulate a large variety of cellular processes. Conse-
quently, deregulation of miRNAs results in many diseases includ-
ing cancer. The let-7 family consists of 13 sequence-conserved
members located on nine different chromosomes and is function-
ally conserved from Caenorhabditis elegans to humans. Let-7s are
down-regulated in many malignancies and widely viewed as
tumor suppressors. Given the functional redundancy and co-
repression of let-7s in tumors, the presence of a common mech-
anism to coordinately inhibit let-7s was anticipated. Consistently,
several studies revealed that the lin28 family members, i.e., Lin28
and Lin28B, are both targets and inhibitors of let-7s [1–3]. More-Journal of Hepatology 20
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E-mail address: xw3u@nih.gov (X.W. Wang).tumors. Taken together, these results indicate that lin28s may
promote transformation by targeting let-7 and that the intricate
balance between lin28 and let-7 may be critical for regulating
tumor development and progression.
In this manuscript, Viswanathan et al. examined the role of
lin28 in cellular transformation and its functional link with let-
7 [4]. They ﬁrst demonstrated that lin28 facilitates cellular
transformation in different cell lines. Consistently, lin28 is over-
expressed in various human cancer cell lines and in different
types of primary tumors. Moreover, lin28 expression is associated
with advanced disease progression across multiple tumor types
including hepatocellular carcinoma (HCC). Interestingly, all of
the lin28-associated activities are tightly linked to its suppression
of let-7 expression and consequently of let-7 targets. Further-
more, they observed that the lin28/let-7 signaling link is only
applicable to a subset of HCC patients with high-grade tumors
and a high incidence of early recurrence [4]. This study is encour-
aging and is the ﬁrst example that convincingly demonstrates the
critical role of the intricate balance between lin28 and let-7 in
cellular transformation and tumor progression.
We suggest that lin28/let-7 signaling link can be viewedmuch
like a Yin-Yang balancing act (Fig. 1), based on the ancient Chi-
nese scientiﬁc thinking of how things work. The Yin-Yang theory
suggests that the ‘universe’ is governed by the balance of Yin and
Yang, where Yin represents the negative element while Yang rep-
resents the positive element. Consistent with this concept, lin28
and let-7 have been shown to have opposing expression patterns
and functions in development and tumor progression.
The opposing expression patterns and the functional roles of
Lin28 and let-7 are found throughout the development, from
embryo to adult. In embryonic stem cells, the level of lin28 is very
high while let-7 is extremely low. Lin28 is then gradually reduced
while let-7 is gradually increased during development. Function-
ally forced expression of let-7 in stem cells leads to differentia-
tion while exogenous lin28 and other factors can reprogram
differentiated cells toward ‘‘stemness”. It is conceivable that loss
of this balance would be detrimental, which would result in
abnormal differentiation or cancer. Consistent with the above
view, there is growing evidence that an aberrant balance of
lin28/let-7, as in the data presented by Viswanathan et al., is
linked to human malignancies. Consequently, down-regulation
of let-7 along with up-regulation of lin28 is frequently found in
various human tumors including HCC and is associated with
HCC metastasis [4–6]. Interestingly, the opposing expression
pattern of lin28 and let-7 is only found in HCC with an advanced10 vol. 53 j 974–975
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Fig. 1. A Yin-Yang balancing act of the lin28/let-7 link in cellular differentiation
and tumor progression. The lin28/let-7 signaling network can be visualized by the
ancient Chinese Yin-Yang symbol where lin28 represents Yang and let-7
represents Yin.
JOURNAL OF HEPATOLOGYstage and in poorly differentiated ovarian tumors, suggesting that
this Yin-Yang imbalance is mainly associated with tumor pro-
gression [4,7]. Encouragingly, silencing of lin28 or re-induction
of let-7 in HCC or ovarian cancer cells can inhibit tumor cell pro-
liferation [4,6,7].
The connection between the lin28/let-7 signaling link and
oncogenesis is further supported by the observation that this sig-
naling pathway is also associated with several oncogenes such as
c-myc and NF-jB in inducing cell transformation [8,9]. Impor-
tantly, the activation of Lin28 by c-myc and NF-jB is necessary
and sufﬁcient for oncogene-mediated let-7 repression. Thus, an
imbalance between lin28 and let-7 induced by Myc and NF-jB
can result in cellular transformation.
Mechanistically, let-7s suppresses the expression of lin28
through let-7-binding sites in the lin28 30UTR [3]. Moreover,
lin28 suppresses the production of mature let-7s at multiple lev-
els. For example, lin28 binds to the loop region of the precursor of
let-7, which blocks the let-7 processing at both the Drosha and
Dicer steps [1]. In addition, lin28 induces 30-terminal uridylation
of let-7 precursors, leading to the failure of Dicer processing and
ﬁnally to degradation [2]. Therefore, both lin28 and let-7 are
involved in the same negative feedback loop to regulate cellular
processes.
The lin28/let-7 signaling link plays a critical role in regulating
cellular homeostasis during human development. An imbalance
in this link leads to abnormal differentiation and cellular trans-
formation. Therefore, reprograming of the lin28/let-7 signaling
link would undoubtedly show therapeutic beneﬁts. It is interest-
ing to point out that lin28 may be a key player leading to onco-
genesis via its locus ampliﬁcation [4] or myc and NF-jB-Journal of Hepatology 201mediated signaling [8,9]. Therefore, lin28 may have additional
functions other than suppressing let-7. It is of interest to further
explore additional downstream signaling molecules of lin28 and
its association with the let-7 network. These studies may also
help us understand other developmental processes, such as aging.
In addition, the lin28/let-7 signaling link may be applicable to
cancer stem cells since down-regulation of let-7 in HCC with can-
cer stem cell features has been reported [6,10]. Taken together,
research into the molecular networks of lin28 and let-7 has
improved our understanding of the intricate microRNA regula-
tory circuit. The exploitation of such a circuit with the use of
the Yin-Yang concept may allow us to identify novel therapeutic
strategies useful in human cancer.Conﬂict of interest
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